Affluent Medical SA (EPA: AFME)

Market Cap	56.25M
Revenue (ttm)	1.30M
Net Income (ttm)	-17.04M
Shares Out	39.34M
EPS (ttm)	-0.54
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,005
Open	1.520
Previous Close	1.520
Day's Range	1.405 - 1.535
52-Week Range	1.190 - 2.300
Beta	0.61
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 27, 2024

About Affluent Medical

Affluent Medical SA develops minimally invasive medical devices in the field of urology and structural heart in France. It offers Artus, an implantable electro-mechanical artificial sphincter that targets moderate to severe urinary incontinence; and Kalios and Epygon implants for the treatment of mitral insufficiency, as well as Kardiozis technology for treating abdominal aortic aneurysm. The company was founded in 2011 and is based in Aix-en-Provence, France.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2011
• Employees: 63
• Stock Exchange: Euronext Paris
• Ticker Symbol: AFME

Financial Performance

In 2023, Affluent Medical's revenue was 1.22 million, a decrease of -8.59% compared to the previous year's 1.34 million. Losses were -15.65 million, 2.80% more than in 2022.